14 results · 21ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

MITEK CUFFTACK

FDA 510(k)
FDA Class 2 ·Orthopedic

Custom Procedure Kit

FDA UDI
MEDIVATORS INC.·40677964021167·The ENDO CARRY-ON Procedure Kit contains all of...

SOLIDEA

FDA UDI
CALZIFICIO PINELLI SRL·08300496003076·NAOMI 30, SIZE S, VISONE, GRADUATED COMPRESSION...

Oph. Cystotomes

FDA UDI
KATENA PRODUCTS, INC.·00841668113745·CCC CYSTOTOME FORMED 27GA

SYNCHRON VANCOMYCIN REAGENT

FDA Adverse Event
BECKMAN COULTER INC.·Product code LEH·June 10, 2011

CELL-CHEX

FDA 510(k)
FDA Class 2 ·Hematology

SPECIALTY 42 (HEFILCON A) HYDROPHILIC CONTACT LENS FOR DAILY WEAR, SPECIALTY T-42 TORIC (HEFILCON A) HYDROPHILIC CONTACT

FDA 510(k)
FDA Class 2 ·Ophthalmic

MECHANICAL (MANUAL) WHEELCHAIR

FDA Adverse Event
Malfunction ·INVACARE TAYLOR STREET·Product code IOR·March 13, 2013

CUSTOM EXTRACTOR AND PIN PULLER

FDA Adverse Event
Malfunction ·STRYKER ORTHOPAEDICS MAHWAH·Product code LXH·February 8, 2011

IMPLANTIUM

FDA Adverse Event
Other ·DENTIUM CO., LTD.·Product code DZE·February 22, 2008

HEARTMATE 3 LVAS IMPLANT KIT

FDA Adverse Event
Injury ·THORATEC CORPORATION·Product code DSQ·October 1, 2020

UUltrasound System 2300, bkActiv w/battery; Model No. 2300-11; System, Imaging, Pulsed Doppler, Ultrasonic

FDA Enforcement
Class II ·Ongoing·B-K Medical A/S·November 12, 2025

Boston Scientific/Cameron Health SQ-RX Model 1010 subcutaneous pulse generators. The S-ICD System is intended to provide therapy for the treatment of life-threatening ventricular tachyarrhythmias.

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·March 27, 2013

CADD-Solis Ambulatory Infusion Pumps, Model 2100. Intended for the following uses: Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.

FDA Enforcement
Class I ·Ongoing·Smiths Medical ASD Inc.·August 14, 2024